The PE Ratio as of November 2024 (TTM) for DURECT Corporation (DRRX) is -2.20

According to DURECT Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -2.20. This represents a change of -29.56% compared to the average of -3.12 of the last 4 quarters.

DURECT Corporation (DRRX) Historical PE Ratio (quarterly & annually)

How has DRRX PE Ratio performed in the past?

The mean historical PE Ratio of DURECT Corporation over the last ten years is -26.19. The current -2.20 PE Ratio has changed 740.16% with respect to the historical average. Over the past ten years (40 quarters), DRRX's PE Ratio was at its highest in in the December 2020 quarter at 24.13. The PE Ratio was at its lowest in in the September 2019 quarter at -44.39.

DURECT Corporation (DRRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of DURECT Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DURECT Corporation (DRRX) Average PE Ratio

How has DRRX PE Ratio performed in the past?

The current PE Ratio of DURECT Corporation (DRRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

DURECT Corporation (DRRX) PE Ratio vs. Peers

How is DRRX’s PE Ratio compared to its peers?

DURECT Corporation’s PE Ratio is greater than Shuttle Pharmaceuticals Holdings, Inc. (-3.82), less than Mallinckrodt plc (-0.00), greater than Organogenesis Holdings Inc. (-52.30), less than Lucy Scientific Discovery Inc. (-0.72), greater than Alimera Sciences, Inc. (-20.50), greater than Alpha Teknova, Inc. (-8.30), less than Agile Therapeutics, Inc. (-0.65), greater than Sonoma Pharmaceuticals, Inc. (-10.24), less than Eagle Pharmaceuticals, Inc. (0.27), less than Lifecore Biomedical, Inc. (28.23), less than RedHill Biopharma Ltd. (2.15), less than Taro Pharmaceutical Industries Ltd. (29.99), less than Collegium Pharmaceutical, Inc. (10.61), less than Neurocrine Biosciences, Inc. (31.55), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Ironwood Pharmaceuticals, Inc. (72.24), less than Alkermes plc (13.05), greater than Avadel Pharmaceuticals plc (-13.44), greater than Aquestive Therapeutics, Inc. (-18.19), less than Evoke Pharma, Inc. (-1.20), less than Adamis Pharmaceuticals Corporation (-0.47), less than Guardion Health Sciences, Inc. (-0.70), less than AcelRx Pharmaceuticals, Inc. (-1.83),

Build a custom stock screener for DURECT Corporation (DRRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DURECT Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DURECT Corporation (DRRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DURECT Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.